Top Story

EDs not major contributor to opioid prescriptions

January 17, 2018
In the Journals

Effectiveness of FDA-approved anti-nausea drug during pregnancy questioned

January 17, 2018
An examination appearing in PLOS One of an unpublished study from 2009 suggested that information the FDA used to approve doxylamine-pyridoxine for treatment of nausea…

Flu widespread in US; no antiviral resistance reported

January 17, 2018
Influenza is widespread across virtually the entire continental United States this season, and H3N2 remains the dominant circulating strain, CDC officials said during a…

FDA accepts application for new Humira biosimilar

January 16, 2018
Sandoz announced that the FDA has accepted a biologics license application for a proposed biosimilar of the anti-inflammatory drug adalimumab, known commercially as…
More Headlines »

Overcoming Barriers and Best Practices for Use of Biosimilars: Conversations Between Physicians and Pharmacists

This activity is supported by an educational grant from Pfizer, Inc.

As more biosimilars are approved for use in the United States, all members of the multidisciplinary care team will…
More »
GI Bookshelf

Chapter 5: Bowel Obstruction And Pseudo-Obstruction

From GI Emergencies: A Quick Reference Guide
More »
Resource Centers
American Heart Association Scientific Sessions

American Heart Association Scientific Sessions

Meeting News Coverage

VIDEO: Storgard discusses lesinurad therapy for patients with gout

February 24, 2016
More »